.png)
Antibiotics Market By Drug Class and Action Mechanism - Global Industry Analysis And Forecast To 2027
Published On : March 2019 Pages : 140 Category: Pharmaceuticals Report Code : HC032817
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Antibiotics Market By Drug Class (Sulfonamides, Cephalosporin, Aminoglycosides, Penicillin, Carbapenem, Fluoroquinolone, Macrolides and Other Drug Classes) and Action Mechanism (Mycolic Acid Inhibitors, DNA Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors and Protein Synthesis Inhibitors) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The antibiotics are the ground-breaking meds that battle the bacterial diseases. Utilized appropriately, the antibiotics may save lives. These meds either eliminate microbes or shield them from imitating. The natural defenses of the body can for the most part take it from that point. These meds are also responsible for fighting infections caused by different viruses. Therefore, the Antibiotics Market is anticipated to expand and has tremendous scope during the forecast period. The global Antibiotics Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
By Drug Class the market is segmented into Sulfonamides, Cephalosporin, Aminoglycosides, Penicillin, Carbapenem, Fluoroquinolone, Macrolides and Other Drug Classes. The Other Drug Classes section is leading the market due to increasing development of the monoclonal antibodies, etc.
By Action Mechanism the market is segmented into Mycolic Acid Inhibitors, DNA Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors and Protein Synthesis Inhibitors. The RNA Synthesis Inhibitors section is seeing substantial growth due to increasing development of different antiviral drugs and other factors.
Regional Insights
The North American region is leading the global Antibiotics Market owing to factor like; increasing utilization of the branded products, while the Asia Pacific region is showing significant growth due to increasing number of cases related to various diseases, and few other factors.
Antibiotics Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Astellas Pharma Inc.
- Pfizer Inc.
- Eli Lilly and Company
- Janssen Pharmaceuticals
- Bristol Myers Squibb Company
- Abbott Laboratories
- Bayer AG
- GlaxoSmithKline plc
- Novartis AG
- Sanofi S.A.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Antibiotics Market, By Drug Class, Estimates and Forecast, 2017-2027 ($Million)
o Sulfonamides
o Cephalosporin
o Aminoglycosides
o Penicillin
o Carbapenem
o Fluoroquinolone
o Macrolides
o Other Drug Classes
o Antibiotics Market, By Action Mechanism, Estimates and Forecast, 2017-2027 ($Million)
o Mycolic Acid Inhibitors
o DNA Synthesis Inhibitors
o Cell Wall Synthesis Inhibitors
o RNA Synthesis Inhibitors
o Protein Synthesis Inhibitors
o Antibiotics Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Astellas Pharma Inc.
o Pfizer Inc.
o Eli Lilly and Company
o Janssen Pharmaceuticals
o Bristol Myers Squibb Company
o Abbott Laboratories
o Bayer AG
o GlaxoSmithKline plc
o Novartis AG
o Sanofi S.A.
o Antibiotics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Antibiotics Market , By Country
o U.S. Antibiotics Market
o Canada Antibiotics Market
o Mexico Antibiotics Market
o Europe
§ Europe Antibiotics Market , By Country
o Germany Antibiotics Market
o UK Antibiotics Market
o France Antibiotics Market
o Russia Antibiotics Market
o Italy Antibiotics Market
o Rest of Europe Antibiotics Market
o Asia-Pacific
§ Asia-Pacific Antibiotics Market , By Country
o China Antibiotics Market
o Japan Antibiotics Market
o South Korea Antibiotics Market
o India Antibiotics Market
o Southeast Asia Antibiotics Market
o Rest of Asia-Pacific Antibiotics Market
o South America
§ South America Antibiotics Market , By Country
o Brazil Antibiotics Market
o Argentina Antibiotics Market
o Columbia Antibiotics Market
o Rest of South America Antibiotics Market
o Middle East and Africa
§ Middle East and Africa Antibiotics Market , By Country
o Saudi Arabia Antibiotics Market
o UAE Antibiotics Market
o Egypt Antibiotics Market
o Nigeria Antibiotics Market
o South Africa Antibiotics Market
o Rest of MEA Antibiotics Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Antibiotics Market, By Drug Class
5.1. Introduction
5.2. Global Antibiotics Revenue and Market Share by Drug Class (2017-2027)
5.2.1. Global Antibiotics Revenue and Revenue Share by Drug Class (2017-2027)
5.3. Sulfonamides
5.3.1. Global Sulfonamides Revenue and Growth Rate (2017-2027)
5.4. Cephalosporin
5.4.1. Global Cephalosporin Revenue and Growth Rate (2017-2027)
5.5. Aminoglycosides
5.5.1. Global Aminoglycosides Revenue and Growth Rate (2017-2027)
5.6. Penicillin
5.6.1. Global Penicillin Revenue and Growth Rate (2017-2027)
5.7. Carbapenem
5.7.1. Global Carbapenem Revenue and Growth Rate (2017-2027)
5.8. Fluoroquinolone
5.8.1. Global Fluoroquinolone Revenue and Growth Rate (2017-2027)
5.9. Macrolides
5.9.1. Global Macrolides Revenue and Growth Rate (2017-2027)
5.10. Other Drug Classes
5.10.1. Global Other Drug Classes Revenue and Growth Rate (2017-2027)
6. Antibiotics Market, By Action Mechanism
6.1. Introduction
6.2. Global Antibiotics Revenue and Market Share by Action Mechanism (2017-2027)
6.2.1. Global Antibiotics Revenue and Revenue Share by Action Mechanism (2017-2027)
6.3. Mycolic Acid Inhibitors
6.3.1. Global Mycolic Acid Inhibitors Revenue and Growth Rate (2017-2027)
6.4. DNA Synthesis Inhibitors
6.4.1. Global DNA Synthesis Inhibitors Revenue and Growth Rate (2017-2027)
6.5. Cell Wall Synthesis Inhibitors
6.5.1. Global Cell Wall Synthesis Inhibitors Revenue and Growth Rate (2017-2027)
6.6. RNA Synthesis Inhibitors
6.6.1. Global RNA Synthesis Inhibitors Revenue and Growth Rate (2017-2027)
6.7. Protein Synthesis Inhibitors
6.7.1. Global Protein Synthesis Inhibitors Revenue and Growth Rate (2017-2027)
7. Antibiotics Market, By Region
7.1. Introduction
7.2. Global Antibiotics Revenue and Market Share by Regions
7.2.1. Global Antibiotics Revenue by Regions (2017-2027)
7.3. North America Antibiotics by Countries
7.3.1. North America Antibiotics Revenue and Growth Rate (2017-2027)
7.3.2. North America Antibiotics Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Antibiotics by Countries
7.4.1. Europe Antibiotics Revenue and Growth Rate (2017-2027)
7.4.2. Europe Antibiotics Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Antibiotics by Countries
7.5.1. Asia-Pacific Antibiotics Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Antibiotics Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Antibiotics by Countries
7.6.1. South America Antibiotics Revenue and Growth Rate (2017-2027)
7.6.2. South America Antibiotics Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Antibiotics by Countries
7.7.1. Middle East and Africa Antibiotics Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Antibiotics Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Astellas Pharma Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Pfizer Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Eli Lilly and Company
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Janssen Pharmaceuticals
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bristol Myers Squibb Company
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Abbott Laboratories
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Bayer AG
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. GlaxoSmithKline plc
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Novartis AG
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Sanofi S.A.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Global Antibiotics Market Competition, by Manufacturer
9.1. Global Antibiotics Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Antibiotics Price By Region (2017-2017)
9.3. Top 5 Antibiotics Manufacturer Market Share
9.4. Market Competition Trend
10. Antibiotics Market Forecast (2017-2027)
10.1. Global Antibiotics Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Antibiotics Market Forecast by Regions (2017-2027)
10.2.1. North America Antibiotics Market Forecast (2017-2027)
10.2.1.1. United States Antibiotics Market Forecast (2017-2027)
10.2.1.2. Canada Antibiotics Market Forecast (2017-2027)
10.2.1.3. Mexico Antibiotics Market Forecast (2017-2027)
10.2.2. Europe Antibiotics Market Forecast (2017-2027)
10.2.2.1. Germany Antibiotics Market Forecast (2017-2027)
10.2.2.2. France Antibiotics Market Forecast (2017-2027)
10.2.2.3. UK Antibiotics Market Forecast (2017-2027)
10.2.2.4. Russia Antibiotics Market Forecast (2017-2027)
10.2.2.5. Italy Antibiotics Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Antibiotics Market Forecast (2017-2027)
10.2.3. Asia-Pacific Antibiotics Market Forecast (2017-2027)
10.2.3.1. China Antibiotics Market Forecast (2017-2027)
10.2.3.2. Japan Antibiotics Market Forecast (2017-2027)
10.2.3.3. Korea Antibiotics Market Forecast (2017-2027)
10.2.3.4. India Antibiotics Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Antibiotics Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Antibiotics Market Forecast (2017-2027)
10.2.4. South America Antibiotics Market Forecast (2017-2027)
10.2.4.1. Brazil Antibiotics Market Forecast (2017-2027)
10.2.4.2. Argentina Antibiotics Market Forecast (2017-2027)
10.2.4.3. Columbia Antibiotics Market Forecast (2017-2027)
10.2.4.4. Rest of South America Antibiotics Market Forecast (2017-2027)
10.2.5. Middle East and Africa Antibiotics Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Antibiotics Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Antibiotics Market Forecast (2017-2027)
10.2.5.3. Egypt Antibiotics Market Forecast (2017-2027)
10.2.5.4. Nigeria Antibiotics Market Forecast (2017-2027)
10.2.5.5. South Africa Antibiotics Market Forecast (2017-2027)
10.2.5.6. Turkey Antibiotics Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Antibiotics Market Forecast (2017-2027)
10.3. Antibiotics Market Forecast by Drug Class (2017-2027)
10.3.1. Antibiotics Forecast by Drug Class (2017-2027)
10.3.2. Antibiotics Market Share Forecast by Drug Class (2017-2027)
10.4. Antibiotics Market Forecast by Action Mechanism (2017-2027)
10.4.1. Antibiotics Forecast by Action Mechanism (2017-2027)
10.4.2. Antibiotics Market Share Forecast by Action Mechanism (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Antibiotics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Antibiotics Revenue and Revenue Share by Drug Class (2017-2018)
Figure Global Sulfonamides Revenue and Growth Rate (2017-2018)
Figure Global Cephalosporin Revenue and Growth Rate (2017-2018)
Figure Global Aminoglycosides Revenue and Growth Rate (2017-2018)
Figure Global Penicillin Revenue and Growth Rate (2017-2018)
Figure Global Carbapenem Revenue and Growth Rate (2017-2018)
Figure Global Fluoroquinolone Revenue and Growth Rate (2017-2018)
Figure Global Macrolides Revenue and Growth Rate (2017-2018)
Figure Global Other Drug Classes Revenue and Growth Rate (2017-2018)
Table Global Antibiotics Revenue and Revenue Share by Action Mechanism (2017-2018)
Figure Global Mycolic Acid Inhibitors Revenue and Growth Rate (2017-2018)
Figure Global DNA Synthesis Inhibitors Revenue and Growth Rate (2017-2018)
Figure Global Cell Wall Synthesis Inhibitors Revenue and Growth Rate (2017-2018)
Figure Global RNA Synthesis Inhibitors Revenue and Growth Rate (2017-2018)
Figure Global Protein Synthesis Inhibitors Revenue and Growth Rate (2017-2018)
Table Global Antibiotics Revenue by Regions (2017-2018)
Figure North America Antibiotics Growth Rate (2017-2018)
Figure North America Antibiotics Revenue and Growth Rate (2017-2018)
Figure North America Antibiotics by Countries (2017-2018)
Figure North America Antibiotics Revenue (Million USD) by Countries (2017-2018)
Figure United States Antibiotics Growth Rate (2017-2018)
Figure United States Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Antibiotics Growth Rate (2017-2018)
Figure Canada Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Antibiotics Growth Rate (2017-2018)
Figure Mexico Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Antibiotics Growth Rate (2017-2018)
Figure Europe Antibiotics Revenue and Growth Rate (2017-2018)
Figure Europe Antibiotics by Countries (2017-2018)
Figure Europe Antibiotics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Antibiotics Growth Rate (2017-2018)
Figure Germany Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Antibiotics Growth Rate (2017-2018)
Figure France Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Antibiotics Growth Rate (2017-2018)
Figure UK Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Antibiotics Growth Rate (2017-2018)
Figure Russia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Antibiotics Growth Rate (2017-2018)
Figure Italy Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Antibiotics Growth Rate (2017-2018)
Figure Rest of Europe Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Antibiotics Growth Rate (2017-2018)
Figure Asia-Pacific Antibiotics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Antibiotics by Countries (2017-2018)
Figure Asia-Pacific Antibiotics Revenue (Million USD) by Countries (2017-2018)
Figure China Antibiotics Growth Rate (2017-2018)
Figure China Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Antibiotics Growth Rate (2017-2018)
Figure Japan Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Antibiotics Growth Rate (2017-2018)
Figure Korea Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Antibiotics Growth Rate (2017-2018)
Figure India Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Antibiotics Growth Rate (2017-2018)
Figure Southeast Asia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antibiotics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Antibiotics Growth Rate (2017-2018)
Figure South America Antibiotics Revenue and Growth Rate (2017-2018)
Figure South America Antibiotics by Countries (2017-2018)
Figure South America Antibiotics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Antibiotics Growth Rate (2017-2018)
Figure Brazil Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Antibiotics Growth Rate (2017-2018)
Figure Argentina Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Antibiotics Growth Rate (2017-2018)
Figure Columbia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Antibiotics Growth Rate (2017-2018)
Figure Rest of South America Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Antibiotics Growth Rate (2017-2018)
Figure Middle East and Africa Antibiotics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Antibiotics by Countries (2017-2018)
Figure Middle East and Africa Antibiotics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Antibiotics Growth Rate (2017-2018)
Figure Saudi Arabia Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Antibiotics Growth Rate (2017-2018)
Figure United Arab Emirates Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Antibiotics Growth Rate (2017-2018)
Figure Egypt Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Antibiotics Growth Rate (2017-2018)
Figure Nigeria Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Antibiotics Growth Rate (2017-2018)
Figure South Africa Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Antibiotics Growth Rate (2017-2018)
Figure Turkey Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antibiotics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Antibiotics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Astellas Pharma Inc. Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eli Lilly and Company Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Janssen Pharmaceuticals Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bristol Myers Squibb Company Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer AG Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline plc Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis AG Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi S.A. Antibiotics Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Antibiotics Market Share by Manufacturer
Figure Global Antibiotics Revenue and Market Share by Manufacturer
Table Global Antibiotics Price by Region (2017-2017)
Figure Top 5 Antibiotics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Antibiotics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Antibiotics Market Forecast by Regions (2018-2025)
Figure North America Antibiotics Market Forecast (2018-2025)
Figure United States Antibiotics Market Forecast (2018-2025)
Figure Canada Antibiotics Market Forecast (2018-2025)
Figure Mexico Antibiotics Market Forecast (2018-2025)
Figure Europe Antibiotics Market Forecast (2018-2025)
Figure Germany Antibiotics Market Forecast (2018-2025)
Figure France Antibiotics Market Forecast (2018-2025)
Figure UK Antibiotics Market Forecast (2018-2025)
Figure Russia Antibiotics Market Forecast (2018-2025)
Figure Italy Antibiotics Market Forecast (2018-2025)
Figure Rest of Europe Antibiotics Market Forecast (2018-2025)
Figure Asia-Pacific Antibiotics Market Forecast (2018-2025)
Figure China Antibiotics Market Forecast (2018-2025)
Figure Japan Antibiotics Market Forecast (2018-2025)
Figure Korea Antibiotics Market Forecast (2018-2025)
Figure India Antibiotics Market Forecast (2018-2025)
Figure Southeast Asia Antibiotics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Antibiotics Market Forecast (2018-2025)
Figure South America Antibiotics Market Forecast (2018-2025)
Figure Brazil Antibiotics Market Forecast (2018-2025)
Figure Argentina Antibiotics Market Forecast (2018-2025)
Figure Columbia Antibiotics Market Forecast (2018-2025)
Figure Rest of South America Antibiotics Market Forecast (2018-2025)
Figure Middle East and Africa Antibiotics Market Forecast (2018-2025)
Figure Saudi Arabia Antibiotics Market Forecast (2018-2025)
Figure United Arab Emirates Antibiotics Market Forecast (2018-2025)
Figure Egypt Antibiotics Market Forecast (2018-2025)
Figure Nigeria Antibiotics Market Forecast (2018-2025)
Figure South Africa Antibiotics Market Forecast (2018-2025)
Figure Turkey Antibiotics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Antibiotics Market Forecast (2018-2025)
Figure Global Antibiotics Forecast by Drug Class (2018-2025)
Figure Global Antibiotics Market Share Forecast by Drug Class (2018-2025)
Figure Global Antibiotics Forecast by Drug Class (2018-2025)
Figure Global Antibiotics Forecast by Action Mechanism (2018-2025)
Figure Global Antibiotics Market Share Forecast by Action Mechanism (2018-2025)
Figure Global Antibiotics Forecast by Action Mechanism (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|